EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators

Carla M P Ribeiro iD, Matthew G Higgs iD, Marianne S Muhlebach, Matthew C Wolfgang iD, Monica Borgatti iD, Ilaria Lampronti iD, Giulio Cabrini

International Journal of Molecular Sciences · 05.03.2023 · 24 (5) · 5010

DOI: 10.3390/ijms24055010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.03.2023. Verfasst von Carla M P Ribeiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Marsico Lung Institute/Cystic Fibrosis Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Staphylococcal Infections. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, NIH HHS, Cystic Fibrosis Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a new series of therapeutics that correct and potentiate some classes of mutations of the CFTR, have provided a great therapeutic advantage to people with cystic fibrosis (pwCF). The main hindrances of the present CFTR modulators are related to their limitations in reducing chronic lung bacterial infection and inflammation, the main causes of pulmonary tissue damage and progressive respiratory insufficiency, particularly in adults with CF. Here, the most debated issues of the pulmonary bacterial infection and inflammatory processes in pwCF are revisited. Special attention is given to the mechanisms favoring the bacterial infection of pwCF, the progressive adaptation of Pseudomonas aeruginosa and its interplay with Staphylococcus aureus, the cross-talk among bacteria, the bronchial epithelial cells and the phagocytes of the host immune defenses. The most recent findings of the effect of CFTR modulators on bacterial infection and the inflammatory process are also presented to provide critical hints towards the identification of relevant therapeutic targets to overcome the respiratory pathology of pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisStaphylococcal InfectionsAdultHumansCystic Fibrosis Transmembrane Conductance RegulatorLungHost-Pathogen InteractionsPseudomonas aeruginosa

Stichwörter der Autor:innen

CFTR modulatorsPseudomonas aeruginosaStaphylococcus aureusairway epitheliaairway infectionairway inflammationcystic fibrosis

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Marsico Lung Institute/Cystic Fibrosis Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.

ORCID-Profile: Carla M P Ribeiro, Matthew G Higgs, Matthew C Wolfgang, Monica Borgatti, Ilaria Lampronti

Förderung

  • Cystic Fibrosis Foundation
  • NIH HHS
  • Cystic Fibrosis Research Foundation
  • NHLBI NIH HHS
  • National Institutes of Health
  • U.S. Cystic Fibrosis Foundation
  • Italian Cystic Fibrosis Research Foundation

Zitieren

APA

Ribeiro, C. M. P., Higgs, M. G., Muhlebach, M. S., Wolfgang, M. C., Borgatti, M., Lampronti, I., & Cabrini, G. (2023). Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators. International Journal of Molecular Sciences, 24(5), 5010. https://doi.org/10.3390/ijms24055010

Vancouver

Ribeiro CMP, Higgs MG, Muhlebach MS, Wolfgang MC, Borgatti M, Lampronti I, et al. Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators. International Journal of Molecular Sciences. 2023;24(5):5010. doi:10.3390/ijms24055010

BibTeX
@article{Ribeiro2023,
  author = {Ribeiro, Carla M P and Higgs, Matthew G and Muhlebach, Marianne S and Wolfgang, Matthew C and Borgatti, Monica and Lampronti, Ilaria and Cabrini, Giulio},
  title = {Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {5010},
  doi = {10.3390/ijms24055010}
}
Kostenlos starten →